more_reports

Chris Temple

The National Investor

Image: Chris Temple

Chris Temple is editor and publisher of The National Investor. He has had an over 40-year career now in the financial/investment industry. Temple is a sought-after guest on radio stations, podcasts, blogs and the like all across North America, as well as a sought-after speaker for organizations. His ability to help average investors unravel, understand and navigate today's markets is unparalleled; and his ability to uncover "off-the-radar" companies is likewise.



His commentaries and some of his recommendations have appeared in Barron's, Forbes, CBS Marketwatch, Wall Street's Best Investments/The Cabot Group, Kitco.com, the Korelin Economics Report, Benzinga.com, Palisade Radio, Mining Stocks Education, Mining Stock Daily and other media.

Recent Articles about Sarepta Therapeutics Inc.

Expert Shares Thoughts on Six Stocks 11/07/2023

Chris Temple of The National Investors shares a detailed report on stocks from the life science to the energy sector to tell you which he believes are Buys and which you should sell.

Add Back Positions in This Biotech 11/01/2023

Chris Temple of The National Investor shares one stock he believes is currently a Buy, as a gross overreaction caused sell-offs.